AIM ImmunoTech
14 hedge funds and large institutions have $2.57M invested in AIM ImmunoTech in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
8% more funds holding
Funds holding: 13 → 14 (+1)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
48% less capital invested
Capital invested by funds: $4.91M → $2.57M (-$2.34M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$52.4K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$36.3K |
| 3 |
WPW
Waldron Private Wealth
Bridgeville,
Pennsylvania
|
+$12.1K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.03K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$222K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$32.2K |
| 3 |
Renaissance Technologies
New York
|
-$16.1K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$13K |
AIM Hedge Fund Activity: Q4 2016 in Review
14 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2016, worth a combined $2.57M — down 48% from $4.91M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new AIM positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $52.4K. The largest seller was Anson Funds Management, cutting an estimated $222K.
- 14 institutional investors held AIM ImmunoTech (AIM) as of Q4 2016, up from 13 in Q3 2016.
- Funds reported $2.57M of AIM ImmunoTech stock for Q4 2016, down 48% quarter-over-quarter.
- 2 funds opened new AIM ImmunoTech positions in Q4 2016 and 1 closed out, a net change of +1 holder.
- The largest AIM ImmunoTech buyer in Q4 2016 was Susquehanna International Group, an estimated $52.4K added.
- The largest AIM ImmunoTech seller in Q4 2016 was Anson Funds Management, an estimated $222K sold.
Based on aggregated 13F filings for Q4 2016.